Cite Filings / HOWL / 0001193125-26-046463

Feed Companies Filings Check

Sign in

SCHEDULE 13G/A

Statement of Beneficial Ownership

Werewolf Therapeutics, Inc. Filed 2026-02-11 Acc 0001193125-26-046463

Documents 1

SCHEDULE 13G/A Statement of Beneficial Ownership , xslSCHEDULE_13G_X01/primary_doc.xml

Around this filing

2026-02-13 8-K Exit or restructuring costs · Executive or director change · Regulation FD disclosure
2026-02-11 SCHEDULE 13G/A Statement of Beneficial Ownership
2026-02-06 8-K Delisting notice
2025-08-14 SCHEDULE 13G/A Statement of Beneficial Ownership

Link to a passage

Paste a passage to link it

At least 12 characters, not counting spaces, so the link points to one passage.

External

SEC EDGAR (opens in new tab)

Loading xslSCHEDULE_13G_X01/primary_doc.xml…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…